Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | TGM2 |
| Upstream (Parents) |
|---|
| (<<) CASP1 → TGM2 |
| (<<) CASP10 → TGM2 |
| (<<) CASP4 → TGM2 |
| (<<) DUSP5 → TGM2 |
| (<<) GRN → TGM2 |
| (<<) HLA-DOA → TGM2 |
| (<<) HSD11B1 → TGM2 |
| (<<) INPP5D → TGM2 |
| (<<) JAK3 → TGM2 |
| (<<) KIAA1949 → TGM2 |
| (<<) KYNU → TGM2 |
| (<<) LCP1 → TGM2 |
| (<<) LTB → TGM2 |
| (<<) MLKL → TGM2 |
| (<<) MPP1 → TGM2 |
| (<<) NFKBIE → TGM2 |
| (<<) PIK3CG → TGM2 |
| (<<) PIK3R5 → TGM2 |
| (<<) PTAFR → TGM2 |
| (<<) SERPINB1 → TGM2 |
| (<<) SH3TC1 → TGM2 |
| (<<) STAT4 → TGM2 |
| (<<) VAV1 → TGM2 |
| (<<) ZBED2 → TGM2 |
| Downstream (Children) |
|---|
| TGM2 → BCL2A1 (>>) |
| TGM2 → CBL (>>) |
| TGM2 → CCDC3 (>>) |
| TGM2 → CSNK1D (>>) |
| TGM2 → EMILIN2 (>>) |
| TGM2 → GBP2 (>>) |
| TGM2 → KRT1 (>>) |
| TGM2 → MAP3K8 (>>) |
| TGM2 → NFKB1 (>>) |
| TGM2 → PTGS1 (>>) |
| TGM2 → SMAD2 (>>) |
| TGM2 → TFPI2 (>>) |
